03 Profile
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
Eleanor Thomas
MD, PhD, assistant professor of neurology at Emory University School of Medicine and co-principal investigator of the study
press citation on 1 topic since 10 Nov 2026 · last quoted 10 Nov 2026
02 Quoted on · 1 of 29 topics
Eleanor Thomas: key facts
- Kind of voice
- Academic
- Role
- MD, PhD, assistant professor of neurology at Emory University School of Medicine and co-principal investigator of the study
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 10 Nov 2026
04 The signal · where Eleanor Thomas sits on rare diseases
Ranked 49= of 100 voices quoted in the press on rare diseases, level with 51 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1Giles LomaxSector leaderChief Executive Officer, Spinal Muscular Atrophy UK (SMA UK)9
- 2Dr Harrison CarterAcademicDirector of Screening at NHS England8
- 3=
Prof Dame Sue HillRegulatorChief Scientific Officer for England and Senior Responsible Officer for Genomics, NHS England7 - 49=Bushra TbakhiAcademicUniversity of Cincinnati, Ohio; lead researcher on the second EoE study1
- 49=Talal NsouliAcademicGeorgetown University, Washington DC; lead researcher on the first EoE study1
- 49=Eleanor ThomasAcademicMD, PhD, assistant professor of neurology at Emory University School of Medicine and co-principal investigator of the study1
- 49=Gonzalo Olmedo-SauraAcademicResearcher, Movement Disorders Research Group, Institut de Recerca Sant Pau; first author of the study1
- 49=Ianthe PitoutClinicianDr, molecular geneticist, Murdoch University Personalised Medicine Centre1
Showing the leaders and the ranks around 49=, of 100 voices · See every voice on the topic →
05 On the record · press
What Eleanor Thomas has said
- technologynetworks.com1
Where Eleanor Thomas has been quoted
- 01Blood Protein Panel Shows Promise for Earlier ALS Diagnosistechnologynetworks.com · 10 Nov 2026
Verbatim
“ALS is a complex disease, and relying on a single biomarker doesn't capture the full picture. By combining proteins associated with different aspects of the disease, including nerve-cell injury and inflammation, we were able to identify ALS with much greater accuracy.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Coventry tot's heartbreaking health battle after 'extremely rare' diagnosiscoventrytelegraph.net
- Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdlereuters.com
- 'Immoral lottery' - Mum's plea after losing daughter to rare diseasethewestmorlandgazette.co.uk
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.